CMS Officials Stress Coverage Decision Timeline At ACLA Panel
Executive Summary
Device developers who want to ensure the best possible reimbursement for their products should be thoughtful in how they approach the US Centers for Medicare and Medicaid Services, agency officials said during a recent meeting.